Medigene AG Announces CEO Departure and Leadership Changes Amid Insolvency Proceedings
I'm PortAI, I can summarize articles.
Medigene AG has announced the departure of CEO Dr. Selwyn Ho, effective July 24, 2025, with Ralph Schäfer set to take over on July 25, 2025. This leadership change comes amid ongoing preliminary insolvency proceedings, though it is stated to be unrelated. The company has also seen other key personnel departures, including its Chief Scientific Officer. The latest analyst rating for Medigene stock (DE:MDG1) is a Buy, with a price target of EUR2.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments